A cartilage repair product developed by co.don AG of Germany received a positive opinion from the European Medicines Agency on 19 May, making it the ninth advanced therapy medicinal product (ATMP) to be assessed for marketing in Europe. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Regulation & Policy
